- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
HBA Announces 2020 ACE Award Winners
Women’s leadership and mentoring initiatives garner Healthcare Businesswomen’s Association top honors for BD, GSK, Surgical Care Affiliates, and Walgreens Boots Alliance.
The Healthcare Businesswomen’s Association (HBA) will be recognizing BD (Becton, Dickinson and Company) GSK, Surgical Care Affiliates and Walgreens Boots Alliance as 2020 ACE Award winners for exemplary workplace initiatives that are working to close the gender and racial inequities in the healthcare and life sciences industry. The awards will be presented on Nov. 19.
HBA’s Advancement, Commitment and Engagement (ACE) Awards recognize companies committed to ensuring that gender diversity and leadership opportunities for women are part of their organizational DNA. An independent review panel of healthcare industry leaders selects ACE Award recipients for their excellence in advancing their female talent and removing the systemic barriers preventing timely progress to parity. Award criteria include measurable results, business performance, stewardship, execution, and sustainability.
The BD Women’s Initiative Network (WIN) earned recognition for re-thinking how mentoring programs can better drive career advancement and opportunities for all associates. GSK (GlaxoSmithKline) garnered honors for their Women’s Leadership Initiative (WLI), which embraces a culture of inclusion with women and men working side by side, and empowers women to realize their full potential without limitations.Surgical Care Affiliates (SCA) was selected as an award recipient for championing a Women’s Leadership Network that has resulted in significant growth in female leaders across the entire enterprise. Walgreens Boots Alliance has merited honors for its highly engaged Women of WBA business resource group (BRG). Initially established as a U.S. group, the BRG has evolved into a global network focused on increasing representation of women and People of Color across the company.
Throughout the year, the honorees’ programs are showcased across the HBA’s extensive community of healthcare and life science companies and are sought out by their peers for insights. A list of previous ACE awards recipients can be found here.
For more information on this year’s recipients, click here.
Johnson & Johnson Seeks FDA Approval for Subcutaneous Tremfya Regimen for Ulcerative Colitis
November 22nd 2024Johnson & Johnson has submitted a supplemental Biologics License Application to the FDA for a subcutaneous induction regimen of Tremfya for adults with moderately to severely active ulcerative colitis based on positive Phase III ASTRO trial results.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
